Bispecific Antibody DR-0202

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A bispecific antibody that simultaneously targets and binds to two as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, bispecific antibody DR-0202 targets and binds to two as of yet undisclosed antigens, thereby redirecting myeloid cells to kill tumor cells. This may also activate the adaptive immune response, further killing tumor cells.

**Synonyms:** - DR 0202 - DR-0202 - DR0202